ClinicalTrials.gov
ClinicalTrials.gov Menu

Aromasin® Non-Interventional Study Of Early Invasive Breast Cancer Patients In China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01176916
Recruitment Status : Recruiting
First Posted : August 6, 2010
Last Update Posted : April 18, 2018
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 1, 2018
  Estimated Study Completion Date : December 1, 2018